In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

Home-fermented foods are great– they’re healthier, more flavourful, and cheaper than store-bought alternatives. What they ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...